Guardant Health's 15min chart shows MACD Death Cross, KDJ Death Cross signals.

According to Guardant Health's 15-minute chart, a MACD Death Cross and KDJ Death Cross occurred on August 27, 2025 at 15:15. This indicates that the stock price has the potential to continue declining, as the momentum of the stock price is shifting towards the downside and may experience further decreases.

Guardant Health Inc. (NASDAQ: GH) has been experiencing significant market fluctuations, with a notable development on August 27, 2025, at 15:15. According to the 15-minute chart, the stock encountered a MACD Death Cross and KDJ Death Cross, indicating a potential shift in the stock's momentum towards the downside [1]. This technical indicator suggests that the stock price may continue to decline, as the momentum is changing direction.

The MACD (Moving Average Convergence Divergence) Death Cross occurs when the MACD line crosses below the signal line, signaling a potential change in the stock's trend. Similarly, the KDJ (Kelvin, Javits, and Divergence) Death Cross indicates a significant change in the stock's momentum, often leading to a downward trend.

Guardant Health's recent financial performance has been mixed. The company reported strong Q2 revenue of $232.1M, surpassing expectations by nearly $21M [1]. However, the company faces challenges, including a negative operating cash flow of $60.3M and a negative EBIT margin of -40.2% [1]. These financial indicators suggest that while the company is performing well in certain areas, it still faces significant operating challenges.

The company's strategic partnerships, such as the one with James Van Der Beek for a colorectal cancer campaign, have been successful in boosting awareness around their Shield blood test [1]. However, the current market sentiment surrounding Guardant Health is cautious, with concerns about the company's financial standing and potential market bubble.

Investors should closely monitor Guardant Health's stock price and technical indicators to make informed decisions. The MACD and KDJ Death Cross signals a potential downward trend, but it is essential to consider the company's overall financial performance and strategic partnerships when evaluating the stock.

References:
[1] https://stockstotrade.com/news/guardant-health-inc-gh-news-2025_08_21/